Medicare Enrolled
Dr. Melissa Babcock, MD
MOHS-Micrographic Surgery Physician · Atlanta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Babcock from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Babcock?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Babcock
Dr. Melissa Babcock is a mohs-micrographic surgery physician in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Babcock performed 2,073 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Babcock received a total of $3,259 from 33 pharmaceutical and/or device companies across 201 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Babcock is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 2,073 Medicare services
$3,259 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,073
Medicare services
Bottom 19% in GA for mohs-micrographic surgery physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
559 | $4 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
409 | $61 | $93 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
194 | $37 | $72 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
168 | $87 | $131 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
133 | $76 | $115 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
116 | $61 | $109 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
78 | $497 | $720 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
71 | $66 | $127 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 57 | $327 | $421 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $38 | $58 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
34 | $213 | $483 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
32 | $251 | $448 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
28 | $30 | $60 |
| Triamcinolone acetonide injection, 1 mg An injection of triamcinolone acetonide, a corticosteroid medication, administered in a 1 mg dose without preservatives. |
28 | $3 | $33 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $119 | $164 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
20 | $100 | $242 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
19 | $100 | $183 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
18 | $33 | $59 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
18 | $42 | $80 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
16 | $491 | $632 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
14 | $261 | $396 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$3,259
Total received (2018-2024)
Avg $466/year across 7 years
Bottom 35% in GA for mohs-micrographic surgery physician
33
Companies
201
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$501
2023
$578
2022
$317
2021
$681
2020
$203
2019
$446
2018
$534
Payments by company (2024)
Galderma Laboratories, L.P.
$90
ABBVIE INC.
$70
Novartis Pharmaceuticals Corporation
$63
E.R. Squibb & Sons, L.L.C.
$58
GENZYME CORPORATION
$37
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
Janssen Biotech, Inc.
$25
PFIZER INC.
$25
Teva Pharmaceuticals USA, Inc.
$25
Dermavant Sciences, Inc.
$24
Biofrontera Inc.
$22
Arcutis Biotherapeutics, Inc.
$20
Kerecis Limited
$12
Top 3 companies account for 44.6% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$1,128
AbbVie Inc.
$392
ABBVIE INC.
$191
Janssen Biotech, Inc.
$176
GENZYME CORPORATION
$173
E.R. Squibb & Sons, L.L.C.
$143
Regeneron Healthcare Solutions, Inc.
$103
AbbVie, Inc.
$94
Novartis Pharmaceuticals Corporation
$93
Sun Pharmaceutical Industries Inc.
$74
LEO Pharma Inc.
$68
PFIZER INC.
$62
Lilly USA, LLC
$56
Genentech USA, Inc.
$54
Arcutis Biotherapeutics, Inc.
$46
SANOFI-AVENTIS U.S. LLC
$43
Ortho Dermatologics, a division of Bausch Health US, LLC
$31
Organogenesis Inc.
$31
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
Teva Pharmaceuticals USA, Inc.
$25
Dermavant Sciences, Inc.
$24
Verrica Pharmaceuticals Inc.
$24
Celgene Corporation
$23
Almirall LLC
$23
Mayne Pharma Inc.
$22
Biofrontera Inc.
$22
Amgen Inc.
$21
UCB, Inc.
$19
MAYNE PHARMA INC.
$16
Promius Pharma LLC
$15
Boston Scientific Corporation
$13
STRATA Skin Sciences, Inc.
$13
Kerecis Limited
$12
Top 3 companies account for 52.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · Cimzia · DERMATITIS - DISEASE · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EPIDUO FORTE · EUCRISA · Erivedge · GENERAL PAIN MANAGEMENT · HUMIRA · Humira · ILUMYA · JUBLIA · Kerecis Omega3 SurgiClose · LUZU LULICONAZOLE · ORACEA · Otezla · Puraply · REMICADE · RINVOQ · SIMLANDI · SKYRIZI · SOOLANTRA · Sernivo Spray · Sotyktu · TALTZ · TREMFYA · TWYNEO · VTAMA · Veltin · Winlevi · XTRAC · YCANTH · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Mohs-micrographic surgery physicians in nearby ZIP areas
16
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Babcock is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Babcock experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Babcock performed 559 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Babcock receive payments from pharmaceutical companies?
Yes. Dr. Babcock received a total of $3,259 from 33 companies across 201 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Babcock's costs compare to other mohs-micrographic surgery physicians in Atlanta?
Dr. Babcock's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Babcock) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Mohs-Micrographic Surgery Physicians in Atlanta
Browse mohs-micrographic surgery physicians in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Mohs-Micrographic Surgery Physicians in GA
Mohs-micrographic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Mohs-Micrographic Surgery Physicians in GA
Which GA mohs-micrographic surgery physicians receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology